Results 241 to 250 of about 1,013,786 (315)

The interplay of the lncRNA AFAP1-AS1 and the soluble immune checkpoint proteins sPD-1/sPD-L1 in breast cancer: tumor-immune cross-talk. [PDF]

Biosci Rep
AbdelHamid SG, El-Housseiny GS, AbdelAziz HM, Kamal AM.   +3 more
europepmc   +1 more source

Targeting Tex10 Overcomes Oxaliplatin Resistance by Competitively Disrupting the Non‐Canonical BAF Complex in Colorectal Cancer

Advanced Science, EarlyView.
This study reveals that Tex10 drives oxaliplatin resistance in colorectal cancer by competitively binding BRD9 to disrupt the ncBAF complex, thereby suppressing AMBRA1 transcription and ULK1‐mediated autophagy. Gemcitabine is identified as a direct Tex10 inhibitor that restores autophagy and overcomes resistance.
Ping Xu, Jie Huang, Xiaojin Gao, Lin Deng, Yanheng Deng, Denglu Wang, Chunlei Yu, Yunxiang Zhang, Jingdong Li, Xiaocong Xiang   +9 more
wiley   +1 more source

Early prediction of metastatic insulinoma using tumor size and biochemical markers: a retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Mathew A, Freudenberg B, Wichert M, Weber F, Schaarschmidt BM, Braegelmann J, Kersting D, Fuhrer D, Lahner H.   +8 more
europepmc   +1 more source

Extracellular vesicles in breast cancer metastasis: functional insights and advances in single-EV analysis. [PDF]

Cancer Metastasis Rev
Lee Y, Wang Y, Graham P, Beretov J, Ni J.   +4 more
europepmc   +1 more source

Functional Mobility as a Prognostic Marker in Geriatric Oncology: A Prospective Study Using Gait Speed. [PDF]

Medicina (Kaunas)
Ünlü B, Demir H, Davarcı SE, Culha Y, Baykara M.   +4 more
europepmc   +1 more source